Management of patients with NTRK fusion-positive lung cancer Review


Author: Drilon, A.
Review Title: Management of patients with NTRK fusion-positive lung cancer
Keywords: genetics; protein kinase inhibitor; lung neoplasms; pathology; protein kinase inhibitors; lung tumor; oncogene proteins, fusion; interview; disease management; drug therapy; therapy; protein tyrosine kinase a; receptor, trka; humans; human; oncogene fusion protein
Journal Title: Clinical Advances in Hematology & Oncology
Volume: 22
Issue: 6 Suppl. 6
ISSN: 1543-0790
Publisher: Millennium Medical Publishing, Inc  
Date Published: 2024-07-01
Start Page: 5
End Page: 9
Language: English
PUBMED: 38953727
PROVIDER: scopus
DOI/URL:
Notes: This work is part of a larger series/topic titled "Efficacy and Safety of NTRK Inhibitors in Patients With NTRK Fusion–Positive Lung and Thyroid Cancers" (PMID: 38953725) -- Source: Scopus
Citation Impact
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon